Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now early-phase tilt small index

E-Cig Use: early-phase trial registry

6 of 10 indexed E-Cig Use trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 6 currently recruiting · #1,724 of 28,707 conditions by registered trial count

E-Cig Use: 10 US clinical trials tracked, 6 recruiting.

E-Cig Use is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 2 in Phase 1-2 (earlier-stage). The most active sponsor is Virginia Commonwealth University, running 2 of these trials.

Enrollment posture brief

Registry condition e-cig-use

OPEN 6 | RECR 60% | LATE 0 | EARLY 2 | RANK #1724 | SPON 2

Nearest open-share peer: Abuse, Drug (60% recruiting · 5 trials)

Acute Leukemia of Ambiguous 80%E-Cig Use (this)60%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%
Open-enrollment share among volume-matched conditions near E-Cig Use

E-Cig Use lists 6 open slots (60% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for E-Cig Use on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. E-Cig Use is recruiting above its size-band peers.

    6 of 10 indexed trials (60%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates E-Cig Use research.

    Virginia Commonwealth University accounts for 2 of 10 trials (20%). 9 distinct sponsors appear on at least one study for this condition label.

  3. Typical E-Cig Use enrolment sits around 147 participants.

    Median target enrolment is 147 among the 10 trials that report a genuine target (sentinel values excluded). 5 of those (50%) plan for fewer than 100 participants.

  4. E-Cig Use research is mostly interventional.

    8 interventional and 2 observational studies make up this index (80% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 11Phase 21

Phase Distribution

PhaseTrial count
Phase 1 1
Phase 2 1

Named interventions

Most-linked intervention names on E-Cig Use records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Usual health education curriculum Behavioral
1 trials
AD IT UP media literacy intervention Behavioral
1 trials
Continue electronic cigarettes Behavioral
1 trials
Quit electronic cigarettes Behavioral
1 trials
Nicotine replacement therapy lozenge Drug
1 trials
Nicotine replacement therapy patch Drug
1 trials
Vaping condition Other
1 trials
ECIG Vuse Other
1 trials

US sites by state

Facility locations filed on E-Cig Use trials. A trial with sites in several states counts in each.

Virginia 3 trials
Pennsylvania 2 trials
Vermont 1 trials
South Carolina 1 trials
Ohio 1 trials
New York 1 trials
Georgia 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this E-Cig Use page

10 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This E-Cig Use condition card totals 10 registered trials; most-linked intervention Usual health education curriculum; top US site state Virginia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.